Analysis of Liver Tumors Using Preoperative and Intraoperative Contrast-Enhanced Ultrasound (CEUS/IOCEUS) by Radiologists in Comparison to Magnetic Resonance Imaging and Histopathology

Abstract

Purpose To evaluate the diagnostic significance of preoperatively and intraoperatively performed contrast-enhanced ultrasound (CEUS/IOCEUS) in the diagnosis of liver tumors in comparison to magnetic resonance imaging (MRI) and histopathology.

Materials and Methods Retrospective analysis of 70/317 patients who underwent surgery for liver tumors between January 2012 and October 2015. Findings of CEUS and IOCEUS were compared to MRI. CEUS and IOCEUS were performed using multifrequency linear probes (1 – 5, 6 – 15 MHz) after bolus injection of 1 – 5 ml sulfur hexafluoride microbubbles. The histopathology after surgical resection, MRI morphology (T1, T2, VIBE, diffusion sequences) and wash-in/wash-out kinetics of CEUS were evaluated.

Results In 70 analyzed patient cases, 64 malignant liver lesions could be detected. 6 patients had benign liver lesions. Among the 64 malignant lesions, there were 28 metastases, 24 hepatocellular carcinomas (HCC), 9 cholangiocellular carcinomas (CCC) and 3 gallbladder carcinomas. 2 of the 6 benign liver lesions were hemangiomas, 2 were adenomas, 1 was an FNH and 1 was a complicated cyst. There was no significant difference when determining the lesion’s malignancy/ benignity (p = 1.000). Furthermore, there was no statistical significance between preoperative CEUS and MRI regarding the general differential diagnosis of a tumor (p = 0.210) and the differential diagnosis classification between HCCs (p = 0.453) and metastases (p = 0.250). There was no statistical significance in tumor size (10 mm – 151 mm; mean 49 mm SD +/– 31 mm) and location (tumor size p = 0.579; allocation to liver lobes p = 0.132; segment diagnosis p = 0.121) between preoperatively performed CEUS and MRI. The combination of preoperative MRI and CEUS for lesion detection showed significant differences compared to CEUS or MRI only (p < 0.001 for CEUS; p = 0.004 for MRI). IOCEUS offered the substantial advantage of locating additional liver lesions (p = 0.004 compared to preoperative MRI, p = 0.002 compared to preoperative CEUS). In 10/37 cases (27 %) IOCEUS could locate further liver lesions which had not been identified during CEUS and/or MRI preoperatively, so that operative therapy was adapted accordingly and resection was extended if necessary.

Conclusion CEUS proves to be a dynamic imaging method for preoperative diagnosis of liver tumors showing high diagnostic significance in the characterization of a tumor’s microvascularization, its entity and its size. During liver operations CEUS plays an important role in surgical therapy decisions.

Citation Format

• Huf S, Platz Batista da Silva N, Wiesinger I et al. Analyse von Lebertumorentitäten mittels präoperativer und intraoperativer Kontrastmittelsonografie (CEUS/IOCEUS) durch Radiologen im Vergleich zur Magnetresonanztomografie und zur Histopathologie. Fortschr Röntgenstr 2017; 189: 431 – 440

Key words

CEUS - liver tumor - MRI - histopathology - IOCEUS

• References

• 1 Reis MACR. Baroni RH. Liver-specific magnetic resonance contrast medium in the evaluation of chronic liver disease. Einstein (Sao Paulo, Brazil) 2015; 13: 326-329
• 2 Hammerstingl R. Huppertz A. Breuer J. et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. European radiology 2008; 18: 457-467
• 3 Seitz K. Bernatik T. Strobel D. et al. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI – a prospective comparison in 269 patients. Ultraschall in der Medizin (Stuttgart, Germany: 1980) 2010; 31: 492-499
• 4 Seitz K. Strobel D. Bernatik T. et al. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions – prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreilandertreffen 2008, Davos. Ultraschall in der Medizin (Stuttgart, Germany: 1980) 2009; 30: 383-389
• 5 Strobel D. Seitz K. Blank W. et al. Contrast-enhanced ultrasound for the characterization of focal liver lesions – diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall in der Medizin (Stuttgart, Germany: 1980) 2008; 29: 499-505
• 6 Carvalho CF. Chammas MC. Souza OC. et al. Elastography and Contrast-enhanced Ultrasonography in the Early Detection of Hepatocellular Carcinoma in an Experimental Model of Nonalcoholic Steatohepatitis. Journal of clinical and experimental hepatology 2013; 3: 96-101
• 7 Chiorean L. Cantisani V. Jenssen C. et al. Focal masses in a non-cirrhotic liver: The additional benefit of CEUS over baseline imaging. European journal of radiology 2015; 84: 1636-1643
• 8 Jung EM. Platz Batista da Silva N. Jung W. et al. Is Strain Elastography (IO-SE) Sufficient for Characterization of Liver Lesions before Surgical Resection – Or Is Contrast Enhanced Ultrasound (CEUS) Necessary?. PloS one 2015; 10: e0123737
• 9 Jung EM. Wiggermann P. Stroszczynski C. et al. Ultrasound diagnostics of diffuse liver diseases. Der Radiologe 2012; 52: 706-716
• 10 Wu W. Chen M. Yan K. et al. Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu 2015; 27: 83-89
• 11 Albrecht T. Hohmann J. Oldenburg A. et al. Detection and characterisation of liver metastases. European radiology 2004; 14: P25-P33
• 12 Sporea I. Badea R. Popescu A. et al. Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions – a prospective multicenter study of its usefulness in clinical practice. Ultraschall in der Medizin (Stuttgart, Germany: 1980) 2014; 35: 259-266
• 13 Strobel D. Bernatik T. Blank W. et al. Diagnostic accuracy of CEUS in the differential diagnosis of small (</= 20 mm) and subcentimetric (</= 10 mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial. Ultraschall in der Medizin (Stuttgart, Germany: 1980) 2011; 32: 593-597
• 14 Jung EM. Clevert DA. Schreyer AG. et al. Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: a prospective controlled two-center study. World journal of gastroenterology 2007; 13: 6356-6364
• 15 Donadon M. Costa G. Torzilli G. State of the art of intraoperative ultrasound in liver surgery: current use for staging and resection guidance. Ultraschall in der Medizin (Stuttgart, Germany: 1980) 2014; 35: 500-511 quiz 512–513
• 16 Torzilli G. Botea F. Donadon M. et al. Criteria for the selective use of contrast-enhanced intra-operative ultrasound during surgery for colorectal liver metastases. HPB: the official journal of the International Hepato Pancreato Biliary Association 2014; 16: 994-1001
• 17 Leen E. Ceccotti P. Moug SJ. et al. Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection?. Annals of surgery 2006; 243: 236-240
• 18 Jung EM. Ross CJ. Rennert J. et al. Characterization of microvascularization of liver tumor lesions with high resolution linear ultrasound and contrast enhanced ultrasound (CEUS) during surgery: First results. Clinical hemorheology and microcirculation 2010; 46: 89-99
• 19 Arita J. Ono Y. Takahashi M. et al. Usefulness of contrast-enhanced intraoperative ultrasound in identifying disappearing liver metastases from colorectal carcinoma after chemotherapy. Annals of surgical oncology 2014; 21: S390-S397
• 20 Hyvelin J. Tardy I. Arbogast C. et al. Use of ultrasound contrast agent microbubbles in preclinical research: recommendations for small animal imaging. Investigative radiology 2013; 48: 570-583
• 21 Wildner D. Pfeifer L. Goertz RS. et al. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma. Ultraschall in der Medizin (Stuttgart, Germany: 1980) 2014; 35: 522-527
• 22 Palmieri VO. Santovito D. Marano G. et al. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. La Radiologia medica 2015; 120: 627-633
• 23 Granata V. de Lutio di Castelguidone E. Fusco R. et al. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area. La Radiologia medica 2016; 121: 122-131
• 24 Soyer P. Dohan A. Patkar D. et al. Observational study on the safety profile of gadoterate meglumine in 35499 patients: The SECURE study. Journal of magnetic resonance imaging: JMRI 2016